Search for a command to run...
Insmed Incorporated
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jun 10, 2026 |  Josh GottheimerD | Stock | Sell |
| $1,001 - $15,000 |
| $91.88 |
| $115.61 |
| +25.8% |
| +21.5% |
Aug 8, 2025 |  Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $109.55 | $145.10 | +32.5% | +30.9% |
Jul 7, 2025 | Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $96.95 | $111.26 | +14.8% | +12.8% |
Jun 16, 2025 | Josh GottheimerD | Stock | Buy | $1,001 - $15,000 | $101.59 | $104.59 | +3.0% | -0.9% |
Apr 9, 2025 | Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $67.55 | $65.08 | -3.7% | -6.5% |
Insmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Is Insmed (INSM) The Best Healthcare Stock to Buy Now?
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday
JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $179
Is Insmed's (INSM) Brensocatib Momentum Quietly Reframing Its Respiratory Growth Narrative?